Subscribe to RSS
DOI: 10.1055/s-2003-36802
Isothiazole Ring Formation with Substituted 2-Alkylthio-3-acyl-4-quinolinone Using O-(Mesitylenesulfonyl)hydroxylamine (MSH)
Publication History
Publication Date:
22 January 2003 (online)
Abstract
Isothiazole ring skeleton was formed by the treatment of substituted 2-alkylthio-3-acyl-4-quinolinone with O-(mesitylenesulfonyl)hydroxylamine(MSH). A mixture of alkyl transferred 3-methyl-9-alkyl-4,9-dihydroisothiazolo[5,4-b]quinolin-4-one as a major product and dealkylated 3-methyl-4,9-dihydroisothiazolo[5,4-b]quinolin-4-one as a minor product was obtained from unsubstituted 2-alkylthio-3-acyl-4-quinolinone in the presence of K2CO3. When 2 equivalents of MSH were used in the absence of K2CO3 only dealkylated product was obtained in quantitative yield.
Key words
imine - electrophilic addition - cyclizations - isothiazole - O-(mesitylenesulfonyl)hydroxyl amine
- 1
Komoriya K,Nagata I,Osada Y, andKondo S. inventors; JP 90-183990. ; Chem. Abstr. 1992, 117, 104253 - 2
Romeo G.Bousquet E.Pappalardo MS.Ronsisvalle G.Oliveri S.Cammarata E. Farmaco 1988, 43: 457 - 3
Nagano N.Nakano K.Shibanuma T.Murakami Y.Hara R. J. Antibiot. 1987, 40: 173 -
4a
Cutri CCC.Garozzo A.Siracusa MA.Castro A.Tempera G.Sarva MC.Guerrera F. Antiviral Res. 2002, 55: 357 -
4b
Inglot AD.Machon Z.Wolna E.Wilimowski M.Prandota J. Arch. Immunol. Ther. Exp. 1973, 21: 891 - 5
Aebi J,Ackermann J,Dehmlow H,Maerki H.-P, andMorand O. inventors; PCT Int. Appl. WO 0236584. ; Chem. Abstr. 2002, 136, 369719 -
6a
Kitagawa Y,Ishikawa K,Sawada H,Araki Y,Shigyo T, andAszmann L. inventors; PCT Int. Appl. WO 0177090. ; Chem. Abstr. 2001, 135, 318501 -
6b
Chemla P,Maetzke T, andErtl P. inventors; PCT Int. Appl. WO 9932464. ; Chem. Abstr. 1999, 131, 58832 -
7a
Heil M,Bretschneider T,Kleefeld G,Erdelen C,Turberg A, andMencke N. inventors; Ger. Offen. DE 19736545. ; Chem. Abstr. 1999, 130, 182458 -
7b
Cetusic J, andRieder BJ. inventors; PCT Int. Appl. WO 0224691. ; Chem. Abstr. 2002, 136, 279447 -
7c
Assmann L,Kitagawa Y,Ishikawa K,Sawada H,Araki Y, andShigyo T. inventors; PCT Int. Appl, WO 0129014. ; Chem. Abstr. 2001 134, 311204 -
7d
Andersch W, andWachendorff-Neumann U. inventors; PCT Int. Appl. WO 0035286. ; Chem. Abstr. 2000, 133, 39470 -
8a
Rahman LKA.Scrowston RM. J. Chem. Soc., Perkin Trans. 1. 1983, 2973 -
8b
Shimizu M.Kikumoto H.Konakahara T.Gama Y.Shibuya I. Heterocycles 1999, 15: 3005 -
8c
Chiyoda T.Iida K.Takatori K.Kajiwara M. Synlett 2000, 1427 -
8d
Zlotin SG.Kislitsin PG.Podgursky AV.Samet AV.Buchanan AG.Gakh AA. J. Org. Chem. 2000, 65: 8439 -
9a
Ikuo I.Kenner CR. J. Heterocycl. Chem. 1978, 15: 1527 -
9b
Noris S. Chem. Pharm. Bull. 1980, 28: 761 -
9c
Hull R.van den Broek PJ.Swain ML. J. Chem. Soc., Perkin Trans. 1 1975, 2271 -
9d
Hull R. J. Chem. Soc., Perkin Trans. 1 1973, 2911 -
9e
Daniel TWC.Claiborne AK. J. Heterocycl. Chem. 1990, 27: 1191 -
10a
Cecchetti V.Fravolini A.Fringuelli R.Schiaffella F. J. Heterocycl. Chem. 1993, 30: 11431 -
10b
Daniel TWC.Claiborne AK. J. Heterocycl. Chem. 1990, 27: 1191 -
11a
Dieter RK.Chang HJ. J. Org. Chem. 1989, 54: 1088 -
11b
Laaman SM.Meth-Cohn O.Rees CW. Synthesis 1999, 757 -
12a
Iijima I.Rice KC. J. Heterocycl. Chem. 1978, 15: 1527 -
12b
Rahman LKA.Scrowston RM. J. Chem. Soc., Perkin Trans. 1. 1983, 2973 -
13a
Stumpf M.Hall H. Liebigs Ann. Chem. 1994, 1049 -
13b
Liu KC.Shin BJ.Hu MK. J. Heterocycl. Chem. 1987, 24: 1729 -
13c
Gunzenhauser S.Ball H. Helv. Chim. Acta 1985, 68: 56 -
14a
Anthony DM.Curtis RM.Christoper A.Ramsden Muhammad RR. Chem. Commun. 1999, 189 -
14b
William LM.Joyce ZZ. J. Org. Chem. 1990, 55: 5791 -
14c
Tamura Y.Sumoto K.Minamikawa J.Ikeda M. Tetrahedron Lett. 1972, 4137 -
15a
Haga N.Endo Y.Kataoka K.Yamaguchi K.Shudo K. J.Am. Chem. Soc. 1992, 114: 9795 -
15b
Kagechika H.Himi T.Namikawa K.Kawaki E.Hasimoto Y.Shudo K. J. Med. Chem. 1989, 32: 1098 -
16a
Keana JW.Heo GS.Gaughan GT. J. Org. Chem. 1985, 50: 2346 -
16b
Luh TY.Chow HF.Leung WY.Tam SW. Tetrahedron 1985, 41: 519 -
17a
Chenault J.Plisson C.Treillard P.Buisson Y.Edmont D. Synth. Commun. 2000, 30: 217 -
17b
Aoki M,Kamata M,Ohtsuka T,Shimma N, andYokose K. inventors; Eur. Pat. Appl. 259804. ; Chem. Abstr. 1988, 109, 73478 -
17c
Wentland MP, andBalley DM. inventors; Eur. Pat.Appl. 90424. ; Chem. Abstr. 1984, 100, 138969 - 22
Guthrie JP. J. Am. Chem. Soc. 1974, 96: 3608 - 23
Johnson CR.Corkins HG. J. Org. Chem. 1978, 43: 4136 -
24a
Segawa J.Kitano M.Kazuno K.Matsuoka M.Shirahase I.Ozaki M.Matsuda M.Tomii Y.Kise M. J. Med. Chem. 1992, 35: 4727 -
24b
Matsuoka M.Segawa J.Makita Y.Ohmachi S.Kashima T.Nakamura KI.Hattori M.Kitano M.Kise M. J. Heterocycl. Chem. 1997, 34: 1773 - Entry 1:
-
25a
Bhat B.Bhaduri AP. Synthesis 1984, 673 -
25b See also:
Meth-Cohn O.Narine B.Tarnowski B. Tetrahedron Lett. 1979, 3111 -
25c Entry 3:
Eiden F.Rademacher G. Arch. Pharm. (Weinheim) 1983, 316: 34 -
25d Entry 4:
Smith JG.Dibble PW.Sandborn RE. J. Org. Chem. 1986, 51: 3762 -
26a
Electrophilic superdelocalizability was calculated with CacheWorkSystem version 3.2 program.
-
26b
Rogers KS.Cammarata A. J. Med. Chem. 1969, 12: 692
References
X-ray crystal structure analysis of 2a and 3f: Atomic coordinates, bond lengths [Å] and angles [deg], anisotropic displacement parameters, hydrogen coordinates, torsion angles [deg] have been deposited at Cambridge Crystallographic Data Centre 12, Union Road. Cambridge. CB2 1EZ, UK. Under deposition number CCDC 192773 for 2a,CCDC 192772 for 3f (Fax: +44(1223)336033, E-mail:deposit@ccdc.cam.ac.uk).
19
Representative
Procedure: To a stirred solution of (1a) (300
mg, 1.28 mmol) in DMF (3 mL) was added K2CO3 (442 mg,
3.2 mmol). After Stirring for 30 min at r.t., MSH (304 mg, 1.41
mmol) was added in small portion during the period of 1 h. The mixture
was stirred at r.t. for 4 h. The solvent was distilled off, and
the residue was partitioned between EtOAc (500 mL) and H2O
(80 mL). The organic layer was separated, washed with brine (50
mL), and dried with anhyd MgSO4. After filtering MgSO4,
the solvent was evaporated under vacuum to give a mixture of crude products
(267 mg) which was separated by column chromatography (hexanes:EtOAc = 3:1)
to afford 3,9-dimethyl-9H-isothiazolo[5,4-b]quinolin-4-one (2a) (162 mg, 55%), 3-methyl-9H-isothiazolo[5,4-b]quinolin-4-one (3a) (83mg, 30%) and 2,4,6-trimethyl-benzenesufonic
acid methyl ester (22 mg, 8%). (2a)
Yield: 55%, Yellow solid,
Rf = 0.41
(CH2Cl2:MeOH = 30:1),
mp 199-200 °C.
1H
NMR (300 MHz, CDCl3): δ = 8.56-8.51
(m, 1 H),
7.79-7.70 (m, 1 H), 7.46-7.37
(m, 2 H), 3.84 (s, 3 H), 2.89 (s, 3 H).13C
NMR (125 MHz, CDCl3): δ = 174.16, 170.24, 168.23,
140.61, 133.17, 127.51, 125.60, 123.29, 118.99, 113.69, 38.46, 21.09.
MS: m/z = 230 (M+),
215, 197, 184, 169. HRMS (EI): calcd for C12H10N2O1S1:
230.0517.
Found: 230.0520. Anal. Calcd for C12H10N2O1S1:
C, 62.59; H, 4.38; N, 12.16; S, 13.92. Found: C, 62.61; H, 4.41;
N, 12.55; S, 13.83. (3a) Yield: 30%,
Yellow solid, Rf = 0.08 (hexanes:EtOAC = 3:1),
mp 342-344 °C. 1H
NMR (200 MHz, DMSO-d
6): δ = 12.75
(s, 1 H), 8.25-8.22 (m, 1 H), 7.78-7.71 (m, 1
H), 7.53-7.49 (m, 1 H), 7.40-7.33 (m, 1 H), 2.72
(s, 3 H).13C NMR (125 MHz, DMSO-d
6): δ = 173.75, 165.97,
165.24, 140.07, 133.20, 125.93, 123.55, 122.93, 118.64, 117.60,
20.35. MS: m/z = 216
(M+), 199, 183, 170, 161. HRMS (EI): calcd for
C11H8N2O1S1:
216.0360. Found: 216.0357. 2,4,6-Trimethyl-benzenesufonic
Acid Methyl Ester: Yield: 8%, Yellow oil, Rf = 0.76
(hexanes:EtOAc = 3:1). 1H
NMR (200 MHz, CDCl3): δ = 6.99 (s,
2 H), 3.70 (s, 3 H), 2.63 (s, 6 H), 2.32 (s, 3 H). MS: m/z = 214 (M+),
196, 182, 174, 165, 149.
1H NMR was run in Bruker AMX 500MHz in DMF-d 7. A mixture of MSH (22 mg) and 1a (12 mg) in 1mL of DMF-d 7 was used and the spectrum was run at an interval of 5 min up to 1 h. After 12th run 3 h, 1 d, 3 d interval spectrum was obtained.
21In order to prepare GCMS sample for low boiling material, reaction was run under the standard condition. After 2 h, low boiling cut was collected using dry ice-acetone trap. The sample was analyzed in HP 5890 series II (GC) and HP5971 series MSD (mass detector). Conditions: capillary column DB-wax 30m × 0.25 mm (0.25 µm film thickness), ion source temperature 200 °C, injection temperature 250 °C: oven temperature 35 °C to ca. 240 °C programmed 10 °C/min, retention time: 2.08 min HCO2Me, 3.47 min MeOH.
27Methylthio group of quinolinone 1a was removed by Raney nickel to provide 3-acyl-4-quinolinone (8) and acyl group of 1a was removed by treatment with trifluoro acetic acid as solvent to give 2-methylthio-4-quinolinone (9). Reaction of 8 or 9 with MSH did not proceed after overnight stirring under the same condition.